London, UK – December 12th 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces the issue by the U.S. Patent and Trademark Office of two new patents exclusively licensed to its portfolio company, Wanda. The patents will significantly extend protection for the core technology used in Wanda’s software application for remote health and patient management. The patents, titled, “Apparatus, System, and Method for Detecting Activities and Anomalies in Time Series Data” and “Efficient Searching of Stationary Datasets” are the result of research on clinical time-series data at UCLA.
Commenting on the news, NetScientific’s Chief Executive Officer and Chairman of Wanda, Francois R. Martelet said: “We are delighted to announce that Wanda is further strengthening its IP, an important step in its continued corporate development. We believe Wanda’s class-leading predictive and behavioural analytics platform acts as a competitive differentiator in the emerging and highly exciting Digital Health sector.”
NetScientific holds a 61% stake on a fully diluted basis in Wanda.
For more information, please contact:
| NetScientific
François R. Martelet, M.D., CEO Ian Postlethwaite, CFO |
Tel: +44 (0)20 3514 1800 |
|
Consilium Strategic Communications Mary-Jane Elliott Jessica Hodgson / Chris Welsh / Laura Thornton
|
Tel: +44 (0)20 3709 5700 netscientific@consilium-comms.com |
| Stifel Nicolaus Europe Limited (NOMAD and Broker)
Jonathan Senior / David Arch / Ben Maddison |
Tel: +44 (0) 20 7710 7600 |
About NetScientific
NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net
Wanda is awarded two patents which increase its ability to detect adverse event scenarios for patients
December 11th 2017
Wanda (http://yourwanda.com/), a leading digital health platform focused on advancing the effectiveness and efficiency of remote patient management and communication, has been awarded two new patents by the U.S. Patent and Trademark Office, for a total of three awarded patents in 2017. The inventions titled “Efficient Searching of Stationary Datasets” and “Apparatus, System, and Method for Detecting Activities and Anomalies in Time Series Data”, are a result of research on clinical time-series data done at UCLA. Anomaly Detection is a cornerstone of effective machine learning in health care. Wanda now has the ability to identify and act upon clinical and patient behavior subtleties which are frequently overlooked and then lead to adverse events.
“We are very excited to be awarded two new patents on the analytical methodologies which drive Wanda’s solutions. These inventions helps us maintain our unique advantages in the space and are strong indicators that intelligent data usage is the driving force behind our products.” said Foad Dabiri, CEO of Wanda, adding “Wanda is all about applying modern software applications powered by analytics, data science and deep healthcare knowledge in a meaningful, personal way that is unique to each patient and in the way nurses, doctors and the full care team can believe and then act on the information provided.”
About Wanda:
Wanda represents the next generation of digital health solutions for patient care via advancing the efficiency of medicine by using machine learning and modern software applications enabling care providers to intelligently monitor, communicate with and manage their patients leading to improved outcomes and efficiencies. More information about Wanda can be found at http://www.yourwanda.com
